In the Brown Norway (BN) rat, mercuric chloride (HgCl 2 ) induces a T h 2-dominated autoimmune syndrome which includes an early phase of mast cell-dependent vasculitis. We have shown in vitro that oxidative stress up-regulates IL-4 in mast cells and predisposes to degranulation. The aim of this study was to determine whether administration of antioxidants inhibits 
Introduction
In the Brown Norway (BN) rats chemical compounds such as mercuric chloride (HgCl 2 ), D-penicillamine or gold salts induce a T h 2-dominated autoimmune syndrome, characterized by the production of various autoantibodies (1,2), a significant increase in serum IgE concentration, tissue injury in the form of a narcotizing vasculitis especially affecting the caecum and an inflammatory polyarthritis (3, 4) . The induction of a necrotizing vasculitis and anti-neutrophil cytoplasm antibody (ANCA) of the anti-myeloperoxidase (MPO) type in BN rats is analogous to human systemic vasculitis, despite the different distribution of vasculitis (2, 5) . The presence of both anti-MPO ANCA and elevated IgE are features of Churg-Strauss vasculitis (6) . The presence of salivary gland infiltrates has parallels with the exocrine predilection of Sjö gren's syndrome (7) . The autoimmune syndrome is known to be T cell depend-ent (8) and the marked increase in IgE concentration implicates the T h 2 subset, as isotype switching to IgE production is dependent on IL-4 (at least in the mouse), a major cytokine product of T h 2 cells (9) .
Although vasculitis peaks at the same time as the serological response~2 weeks after the administration of HgCl 2 , significant vasculitis occurs in the caecum within 24-48 h of an injection of HgCl 2 , a time at which there is no significant T cell infiltrate (10) . Our work has demonstrated a role for mast cells in this early vasculitis (11) . Our previous studies have also shown that IL-4 mRNA expression was up-regulated in the caecum within 24 h of an injection of HgCl 2 in vivo (10) .
In rats, two subtypes of mast cells have been identified based on differences in tissue distribution, biochemical phenotype and histochemical characteristics (12) . Connective tissue mast cells contain the rat mast cell proteases (RMCP)-1, -5, -6 and -7, and carboxypeptidase A (13), while mucosal mast cells express RMCP-2 (or II), -8, -9 and -10 (12,13). Both populations synthesize and secrete chemokines and cytokines (12) , including IL-4. Mast cells are known to be essential resident effector cells in the initiation of allergic responses (12) . There is increasing evidence that mast cells may also function as immunoregulatory cells (14, 15) and that mast cell-derived cytokines, in particular IL-4, are capable of polarizing T cells to differentiate to the T h 2 subset (16). In addition, mast cells store preformed IL-4 within their secretory granules (17) , can release IL-4 within minutes of stimulation (18) and are able to induce IL-4 gene transcription within 90 min of stimulation (19) . All the above indicates that mast cells could play a role in the initiation and amplification of an effective T h 2 response.
We have found that the compounds that cause T h 2 celldriven autoimmunity in BN rats in vivo generate reactive oxygen species (ROS) in the mast cell line RBL-2H3 and in mast cells of BN rats in vitro, and that modulation of ROS production/redox balance within the mast cell modulates the effects of these compounds on mast cell degranulation (20) . Most recently, we have shown that HgCl 2 enhances both IL-4 mRNA and protein expression in RBL-2H3 cells in vitro, that oxidative stress by H 2 O 2 mimics the effects of HgCl 2 in enhancing IL-4 promoter activity and translation, and that antioxidants (sulphydryl and non-sulphydryl containing) diminish the HgCl 2 -induced enhancement of IL-4 (21) . These data suggest a novel mechanism of IL-4 transcriptional upregulation by oxidative stress. We therefore propose the hypothesis that up-regulation of IL-4 and sensitization for mediator release in mast cells, caused by production of intracellular ROS, contributes to HgCl 2 -induced autoimmunity.
The aim of this study was to test this hypothesis by determining whether administration of antioxidants to BN rats inhibits HgCl 2 -induced early vasculitis in vivo, and, if so, to examine whether modulation of oxidative/antioxidative balance influences IgE and IL-4 expression by mast cells in situ. Although we had previously shown that certain antioxidants can diminish HgCl 2 -induced expression of IL-4 at the protein level, as a prelude to the present study we wished to find out whether this was also true for N-acetyl-L-cysteine (NAC), the principle antioxidant we planned to use in vivo.
Methods

Cells and reagents
The rat mast cell line RBL-2H3 was obtained from ATCC (Rockville, MD). The cells were cultured as described previously (21) . HgCl 2 , pyruvate and NAC were purchased from Sigma (Poole, UK). NAC used in vivo was purchased from Evans Medical (Leatherhead, UK), while desferrioxamine was from Ciba (Horsham, UK). Mouse anti-rat IgE and IL-4 mAb were purchased from Serotec (Oxford, UK), as were isotypematched control antibodies.
Treatment of RBL-2H3 cells with NAC and HgCl 2
The day before the experiment, RBL-2H3 cells were removed by trypsinization and seeded to new flasks at a cell density of 2ϫ10 6 /20 ml of medium. The cells were incubated with or without NAC (2ϫ10 -2 M) for 1 h and then cultured in the presence or absence of HgCl 2 (10 -5 M) for 48 h. The same amount of NAC was also added 24 h after addition of HgCl 2 in one of the flasks.
Treatment of rats with antioxidants and HgCl 2
Male BN rats (250-400 g) were purchased from Harlan-Olac (Bicester, UK) and used in age-matched groups. In one group (HgCl 2 ϩ NAC group), rats were given NAC dissolved in drinking water at a concentration of 1 g/l 2 days before and during the experimental period, and injected i.p. with 1 g/kg body wt of NAC solution at -2, 6, 24 and 30 h with respect to injection of HgCl 2 . A second group of animals (HgCl 2 ϩ saline group) was given tap water and injected i.p. with equal volumes of saline at the above time points. All rats were given HgCl 2 s.c. 1 mg/kg at 0 h. In one experiment, a third group of rats (saline ϩ saline group) was injected (i.p. and s.c.) with saline and served as normal controls. A fourth group of rats (saline ϩ NAC group) was given the same dose schedule of NAC as the HgCl 2 ϩ NAC group and a single injection of saline (s.c.) at 0 h. In addition, the non-sulphydryl containing antioxidants desferrioxamine (22) and pyruvate (23) were given in a separate experiment. One group (HgCl 2 ϩ desferrioxamine group) of rats were injected (i.p.) with 0.4 g/kg body weight of desferrioxamine solution and another group of rats (HgCl 2 ϩ pyruvate group) was injected (i.p) with 0.4 g/kg of pyruvate at -2, 0, 6, 24 27 and 30 h. In the HgCl 2 ϩ pyruvate group, rats were given pyruvate in drinking water at a concentration of 2 g/l at 2 h before and during the experimental period. Two additional groups of rats (HgCl 2 ϩ saline group and HgCl 2 ϩ NAC group) were also included in the experiment.
Blood samples were taken from tail vessels at various time points, and serum was stored at -20°C for measurement of RMCP II and IgE concentrations. Animals were killed and scored for macroscopic evidence of vasculitis at 48 h after the start of HgCl 2 by an experienced observer blinded to treatment group. The total macroscopic vasculitis score was the sum of both serosal and mucosal score for each rat (22) . The scoring system has been shown to correlate well with histological vasculitis scores (24) . Biopsies were taken from caecal tissues, and fixed for microscopic vasculitis scores and other histological analysis. Coded histological sections were examined by an experienced histopathologist (D. R. T.).
Histology
Cytospin preparations of RBL-2H3 cells were fixed in alcohol and endogenous peroxidase production blocked with methanol/H 2 O 2 . Antigen retrieval was effected by microwave treatment for 10 min in citrate buffer. The mouse mAb against rat IL-4 (Serotec) at 1:100 dilution in 1% BSA was applied to the cells, and a Dako Envision kit (monoclonal) provided enhancement and the visual marker (diamino-leuzidine). The slides were lightly counterstained with Mayer's haematoxylin.
Directed biopsies from rat caecal mucosa were fixed in formalin and/or Carnoy's fluid prior to paraffin embedding. Sections were cut at 5 µm and stained with haematoxylin & eosin, toluidine blue and choracetate esterase. The immunoperoxidase technique was used on tissue specimens fixed in Carnoy's fluid without antigen retrieval. The animal research kit (ARK) from Dako was employed. Surface IgE ϩ cells were identified using a mouse anti-rat IgE heavy chain mAb (MCA 193; Serotec). For IL-4 staining, the mouse anti-rat IL-4 mAb (Serotec) was used.
Serum RMCP II and total IgE analysis
The rat RMCP II ELISA kit was purchased from Moredun Scientific (Edinburgh, UK) and used according to the manufacturer's instructions. Total IgE was also measured by ELISA (4).
Statistical analysis
Data are expressed as mean Ϯ SEM or median and analyzed using repeated measures analysis of variance or the nonparametric Mann-Whitney U-test and Kruskal-Wallis H-test as appropriate. Two-tailed P values Ͻ0.05 were considered significant.
Results
NAC down-regulates HgCl 2 -enhanced IL-4 production in RBL-2H3 cells
Although some basal expression of IL-4 was detectable in RBL-2H3 cells (Fig. 1A) , the level of the protein was considerably enhanced after HgCl 2 treatment for 2 days (Fig. 1B) . The enhancement of IL-4 protein expression by HgCl 2 was inhibited by adding NAC (Fig. 1C) .
Antioxidants reduce HgCl 2 -induced early vasculitis in BN rats
Administration of HgCl 2 to BN rats (n ϭ 12) induced macroscopic vasculitis in 11 of 12 rats, with a median total vasculitis score of 3.5. Animals (n ϭ 12) treated with both HgCl 2 and NAC showed a decrease in the incidence (four out of 12) and the median total vasculitis score (median ϭ 0) ( Fig. 2A) . There was a significant difference (P ϭ 0.0006, Mann-Whitney U-test) between the severity of macroscopic vasculitis in the two groups. In a separate experiment, rats (n ϭ 10) given saline i.p. and s.c. had no macroscopic vasculitis (data not shown). Microscopic vasculitis score from directed caecal biopsies confirmed the above findings: median score HgCl 2 ϩ saline ϭ 4; HgCl 2 ϩ NAC ϭ1 (P ϭ 0.0003, MannWhitney U-test). These results were confirmed in three further experiments. Figure 2 (B) shows that treatment of the rats with either desferrioxamine or pyruvate decreases the incidence and the median total vasculitis score induced by HgCl 2 injection. These results were confirmed in two separate experiments (including the one shown). Data pooled from the two identical experiments revealed a significant difference in total macroscopic vasculitis score, both between the HgCl 2 ϩ desferrioxamine group and the HgCl 2 ϩ saline group (Kruskal-Wallis, P Ͻ 0.0001), and between the HgCl 2 ϩ pyruvate group and the HgCl 2 ϩ saline group ( P ϭ 0.0043). Figure 3 (A and B) shows typical IgE ϩ and IL-4 ϩ mast cell staining respectively, while Table 1 shows the numbers of IgE ϩ and IL-4 ϩ mast cells in the submucosa of caecums from BN rats given different treatments. Treatment of BN rats with HgCl 2 (HgCl 2 ϩ saline group) significantly increased the number of IgE ϩ mast cells in vivo when compared to controls (saline ϩ saline group) at 48 h (P ϭ 0.0084, Kruskal-Wallis adjusted for ties). Treatment of rats with both HgCl 2 and NAC (HgCl 2 ϩ NAC group) significantly decreased the increased number of IgE ϩ mast cells produced by HgCl 2 (P ϭ 0.0286).
NAC influences HgCl 2 -enhanced IgE and IL-4 expression on mast cells in vivo
Treatment of BN rats with HgCl 2 (HgCl 2 ϩ saline group) significantly increased the number of submucosal mast cells expressing IL-4 when compared with controls (Kruskal-Wallis P ϭ 0.0186) ( Table 1 ). The increase in the number of IL-4 ϩ mast cells seen in BN rats treated with HgCl 2 was decreased by administration of NAC, but this was not statistically significant: there was no significant difference in the numbers of IL-4 ϩ mast cells, either between the HgCl 2 ϩ saline group and the HgCl 2 ϩ NAC group or between the HgCl 2 ϩ NAC group and the saline ϩ saline group. Treatment of BN rats with HgCl 2 (HgCl 2 ϩ saline group) not only increased the number of submucosal mast cells expressing IL-4 molecules but also increased the levels of IL-4 protein expression in individual mast cells (Fig. 3C ) when compared with controls (saline ϩ saline group) (Fig. 3D) . The increased levels of IL-4 expression in the mast cells from rats treated with HgCl 2 (HgCl 2 ϩ saline group) appeared to be modestly reduced by addition of NAC (HgCl 2 ϩ NAC group) (data not shown), although there are no quantitative data available to support this observation. There was no obvious lymphocyte infiltration or IL-4 ϩ T cells present in the tissues of the different groups.
NAC influences serum RMCP II concentration
In BN rats, there was an increased RMCP II concentration in the serum after HgCl 2 injection, reaching a peak at 48 h in the HgCl 2 ϩ saline group (P ϭ 0.013, repeated measures analyses of variance) (Fig. 4A) . The elevated levels of RMCP II stimulated by HgCl 2 were totally abolished by the administration NAC in the HgCl 2 ϩ NAC group. Moreover, the serum levels of RMCP II in the BN rats after HgCl 2 injection were significantly lower than the levels before HgCl 2 administration in the HgCl 2 ϩ NAC group (P ϭ 0.001). In a separate experiment, the serum levels of RMCP II in the rats (saline ϩ NAC group) significantly decreased after NAC administration (P ϭ 0.001) (Fig. 4A) . These indicate that NAC decreases the basal level of serum RMCP II in BN rats.
IgE concentrations
As a possible indicator of T h 2 cell involvement in HgCl 2 -induced early vasculitis, serum total IgE concentrations were measured. There was no significant change in IgE concentrations between the HgCl 2 ϩ saline group and the HgCl 2 ϩ NAC group, although the basal level of IgE concentration is lower in the HgCl 2 ϩ NAC group than that in the HgCl 2 ϩ saline group (Fig. 4B) . In a separate experiment, no significant changes were observed in the saline ϩ NAC group (Fig. 4B ).
Discussion
We have previously reported that exposure of the mast cell line RBL-2H3 to HgCl 2 enhances both IL-4 mRNA and protein expression, and that antioxidants diminish the HgCl 2 -induced enhancement of IL-4 in vitro (21) . In the present study, we demonstrate that the antioxidants NAC, desferrioxamine and pyruvate can reduce HgCl 2 -induced early vasculitis in BN rats in vivo, and that NAC influences HgCl 2 -enhanced IgE and IL-4 expression on mast cells in situ. We have also shown that NAC decreases serum RMCP II concentration. The effectiveness of the non-sulphydryl containing antioxidants suggests that these effects are not due to the chelation of Hg 2ϩ by NAC. This study therefore provides evidence to support our hypothesis that oxidative stress plays a role in the up-regulation of IL-4 and sensitization for mediator release in mast cells in vivo and contributes to HgCl 2 -induced early vasculitis. The study also demonstrates the potential of antioxidants in the treatment of vasculitis.
NAC is a precursor of intracellular glutathione which provides a major cellular defence against oxidative stress (25) . Desferrioxamine is capable of inhibiting the Fenton reaction and hence prevents H 2 O 2 from converting into a highly reactive hydroxyl radical (22) , whereas pyruvate reduces H 2 O 2 to water (23) . NAC has recently been shown to prevent the reduction in renal function induced by an oxidative radiographic contrast agent (26) . In vitro, NAC is capable of reducing HgCl 2 -enhanced IL-4 mRNA (21) and protein expression in the mast cell line RBL-2H3. In vivo, HgCl 2 -induced early vasculitis is markedly reduced by administration of the antioxidants. We had previously found that treatment of BN rats with agents that stabilize mast cells, but not with an antibody to the αβ TCR, significantly ameliorates the early vasculitis (11) . These results suggest that the mast cell plays a role in this early phase of vasculitis. Our present results have shown that the reduction in early vasculitis caused by NAC is accompanied by in vivo evidence of mast cell inhibition (inhibition of the increase in IgE binding to mast cells produced by HgCl 2 and decreased RMCP II concentration); at the same time there is no significant T cell infiltrate or increase in serum IgE concentration. These data strongly suggest that NAC reduces the early vasculitis, at least in part, through inhibition of mast cell function in situ. The mechanism by which NAC inhibits the basal level of RMCP II is unknown. One speculative possibility is that exogenous addition of an antioxidant might block ROS produced during normal cellular metabolism which might, in turn, inhibit their function in cell signalling and regulation in mast cells (27) . The main pathway of mast cell activation is IgE dependent. This activation is initiated through the cross-linking of the high-affinity IgE receptor, FcεRI, on the mast cell membrane, which results in the degranulation of the mast cell and the release of mediators (12) . It has been shown that IgEdependent mast cell function requires mast cells to bind IgE via the FcεRI expressed on the surface of the cells (28) . Our data showing that HgCl 2 increases the number of IgE ϩ mast cells and that NAC inhibits this increase indicate that the oxidative/antioxidative balance might be one of the factors modulating IgE-dependent activation.
Recent studies by other groups have demonstrated that IgE itself can enhance the IgE-binding ability of mast cells from rodents and human (29, 30) , and that IgE increases the ability of mast cells to release preformed mediators or cytokines in response to challenge with specific antigen or anti-IgE antibody (31); in particular, there is a striking effect on the ability of cells to secrete IL-4. Moreover, it has also been shown that IL-4 itself, or in synergy with IgE, coenhanced FcεRI expression and IgE-dependent mediator secretion in mast cells (29, 30) . In contrast, there was no or very little pre-loaded IgE on FcεRI of peritoneal mast cells derived from IL-4-deficient mice (29) . This indicates that IL-4 has the potential to enhance mast cell activation via control of FcεRI expression and IgE binding. Therefore, our finding that NAC inhibited HgCl 2 -enhanced IgE binding on mast cells with a trend to a decrease in IL-4 expression in these cells, may, at least in part, be explained via an effect of mast cellderived IL-4 on IgE-binding capacity in the microenvironment.
IL-4 expression by mast cells is transcriptionally regulated. However, the mechanisms used by mast cells and T h 2 cells are different. IL-4 gene expression in T lymphocytes is more strictly controlled than in mast cells (32) . However, mast cells can release pre-stored IL-4 within minutes of stimulation and start to synthesize more hours after the stimulation. Thus, it is possible that mast cells could be activated and provide an initial source of IL-4 which could induce or expand T cells for an effective T h 2 response. In our present study, a trend to a decrease in HgCl 2 -enhanced IL-4 expression in mast cells produced by the antioxidant NAC was recorded. We do not know at this stage whether the decreased amount of IL-4 is above or below the threshold required for initiation or amplification of an effective T h 2 response.
In conclusion, our data demonstrate that administration of antioxidants to BN rats reduces HgCl 2 -induced early vasculitis, suggesting that oxidative stress plays a role in the pathogenesis of the early vasculitis. This finding may have implications for the understanding of the initiation of this experimental model of T h 2 cell-driven autoimmunity and possibly of analogous human diseases.
